View in EDS HTML Full Text PDF Full Text

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

Saved in:
Bibliographic Details
Title: High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
Authors: Cortellini, Alessio1,2 (AUTHOR) a.cortellini@imperial.ac.uk, Giusti, Raffaele3 (AUTHOR), Filetti, Marco3 (AUTHOR), Citarella, Fabrizio4 (AUTHOR), Adamo, Vincenzo5 (AUTHOR), Santini, Daniele4 (AUTHOR), Buti, Sebastiano6 (AUTHOR), Nigro, Olga7 (AUTHOR), Cantini, Luca8,9 (AUTHOR), Di Maio, Massimo10 (AUTHOR), Aerts, Joachim G. J. V.8 (AUTHOR), Bria, Emilio11,12 (AUTHOR), Bertolini, Federica13 (AUTHOR), Ferrara, Miriam Grazia11,12 (AUTHOR), Ghidini, Michele14 (AUTHOR), Grossi, Francesco15 (AUTHOR), Guida, Annalisa16 (AUTHOR), Berardi, Rossana9 (AUTHOR), Morabito, Alessandro17 (AUTHOR), Genova, Carlo18,19 (AUTHOR)
Source: Journal of Hematology & Oncology. 1/21/2022, Vol. 15 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-022-01226-2